SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Quaker Chemical Corporation (KWR) has a negative trailing P/E of -889.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 16.5 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.11%, forward earnings yield 6.05%. PEG 0.98 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.98); analyst target implies upside (+53.4%).
- Forward P/E 16.5 — analysts expect a return to profitability with estimated EPS of $7.75 for FY2026.
- PEG Ratio 0.98 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield -0.11% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 6.05% as earnings recover.
- Analyst consensus target $196.50 (+53.4% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 56/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — KWR
Valuation Multiples
P/E (TTM)-889.6
Forward P/E16.5
PEG Ratio0.98
Forward PEG0.98
P/B Ratio1.61
P/S Ratio1.17
EV/EBITDA19.9
Per Share Data
EPS (TTM)$-0.14
Forward EPS (Est.)$7.75
Book Value / Share$79.47
Revenue / Share$109.04
FCF / Share$6.98
Yields & Fair Value
Earnings Yield-0.11%
Forward Earnings Yield6.05%
Dividend Yield1.55%
SharesGrow IV$243.17 (+89.8%)
Analyst Target$196.50 (+53.4%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
27.4 |
1.31 |
4.17 |
2.25 |
1.05% |
| 2017 |
98.2 |
-1.47 |
4.88 |
2.43 |
0.93% |
| 2018 |
39.6 |
0.21 |
5.42 |
2.72 |
0.82% |
| 2019 |
78.7 |
-1.48 |
2.01 |
2.20 |
0.88% |
| 2020 |
113.2 |
16.90 |
3.40 |
3.17 |
0.61% |
| 2021 |
33.9 |
0.17 |
2.96 |
2.33 |
0.70% |
| 2022 |
-186.9 |
1.65 |
2.33 |
1.53 |
1.01% |
| 2023 |
33.9 |
-0.04 |
2.76 |
1.95 |
0.83% |
| 2024 |
21.5 |
5.61 |
1.85 |
1.36 |
1.32% |
| 2025 |
-964.3 |
9.44 |
1.75 |
1.27 |
1.43% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.63 |
$746.67M |
$61.4M |
8.2% |
| 2017 |
$1.52 |
$820.08M |
$20.28M |
2.5% |
| 2018 |
$4.47 |
$867.52M |
$59.47M |
6.9% |
| 2019 |
$2.09 |
$1.13B |
$31.62M |
2.8% |
| 2020 |
$2.22 |
$1.42B |
$39.66M |
2.8% |
| 2021 |
$6.77 |
$1.76B |
$121.37M |
6.9% |
| 2022 |
$-1.00 |
$1.94B |
$-17.81M |
-0.9% |
| 2023 |
$6.26 |
$1.95B |
$112.75M |
5.8% |
| 2024 |
$6.55 |
$1.84B |
$116.64M |
6.3% |
| 2025 |
$-0.14 |
$1.89B |
$-2.49M |
-0.1% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$8.01 |
$7.53 – $8.47 |
$1.97B |
$1.96B – $1.99B |
3 |
| 2027 |
$9.43 |
$8.87 – $10.31 |
$2.05B |
$2.03B – $2.07B |
3 |
| 2028 |
$10.87 |
$10.77 – $10.99 |
$2.12B |
$2.12B – $2.12B |
1 |
